BioSpace Movers & Shakers, Dec. 18
The Pharma Data
DECEMBER 17, 2020
Prior to that, Kurtz held a number of leadership positions at various companies, including Monsanto, Nektar Therapeutics, Alza Corporation, Alexza and Novo Nordisk. Cadavid will be responsible for the strategy, direction and execution of the company’s clinical development programs. Previously he was CFO of Voyager Therapeutics.
52 
Let's personalize your content